Pemigatinib - Incyte Corporation
At a glance
- Drug Originator Incyte Corporation
- Drug Licenced by Innovent Biologics; Knight Therapeutics; Specialised Therapeutics Asia
- Drug Class Antineoplastics; Ethers; Fluorobenzenes; Morpholines; Pyridines; Pyrimidinones; Pyrroles; Small molecules
- Mechanism of Action Type 1 fibroblast growth factor receptor antagonists; Type 3 fibroblast growth factor receptor antagonists; Type-2 fibroblast growth factor receptor antagonists
- USA Patent Applicants INCYTE CORP
- USA Patents 6
- NDAs 1
- International Patents 154
- Patent Applications 61
Table of Contents
Disclaimer